Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset

Background: Few studies have reported the epidemiology and clinical outcome of venous thromboembolism (VTE) in Asian patients with pancreatic cancer. This study investigated the incidence, risk factors, and clinical outcome of VTE in patients with pancreatic cancer following palliative chemotherapy....

Full description

Bibliographic Details
Main Authors: Jen-Shi Chen, Chia-Yen Hung, Hung Chang, Chien-Ting Liu, Yen-Yang Chen, Chang-Hsien Lu, Pei-Hung Chang, Yu-Shin Hung, Wen-Chi Chou
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/10/12/501
_version_ 1797764253292167168
author Jen-Shi Chen
Chia-Yen Hung
Hung Chang
Chien-Ting Liu
Yen-Yang Chen
Chang-Hsien Lu
Pei-Hung Chang
Yu-Shin Hung
Wen-Chi Chou
author_facet Jen-Shi Chen
Chia-Yen Hung
Hung Chang
Chien-Ting Liu
Yen-Yang Chen
Chang-Hsien Lu
Pei-Hung Chang
Yu-Shin Hung
Wen-Chi Chou
author_sort Jen-Shi Chen
collection DOAJ
description Background: Few studies have reported the epidemiology and clinical outcome of venous thromboembolism (VTE) in Asian patients with pancreatic cancer. This study investigated the incidence, risk factors, and clinical outcome of VTE in patients with pancreatic cancer following palliative chemotherapy. Methods: The medical records of 838 patients with newly diagnosed locally advanced or metastatic pancreatic cancer who underwent palliative chemotherapy between 2010 and 2016 at four institutes in Taiwan were retrospectively reviewed. The clinical characteristics of all patients were analyzed to identify independent predictors of VTE and their effects on survival outcome. Results: During the median follow-up period of 7.7 months (range, 0.6⁻55.6), VTE occurred in 67 (8.0%) of the 838 patients. Leukocyte count > 11,000/μL and presence of liver metastases were the independent predictors of VTE. Patients with VTE did not show significantly poorer survival outcomes than those without VTE. However, early-onset VTE that occurred within 1.5 months after chemotherapy initiation was an independent negative prognosticator for overall survival. Conclusion: VTE incidence was found to be lower in Asian patients with pancreatic cancer than in their Western counterparts. Early-onset VTE, but not late-onset VTE, is a negative prognosticator for survival outcomes.
first_indexed 2024-03-12T19:53:01Z
format Article
id doaj.art-66f3c36cfc8c454dbb664d362972e597
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T19:53:01Z
publishDate 2018-12-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-66f3c36cfc8c454dbb664d362972e5972023-08-02T03:00:13ZengMDPI AGCancers2072-66942018-12-01101250110.3390/cancers10120501cancers10120501Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early OnsetJen-Shi Chen0Chia-Yen Hung1Hung Chang2Chien-Ting Liu3Yen-Yang Chen4Chang-Hsien Lu5Pei-Hung Chang6Yu-Shin Hung7Wen-Chi Chou8Departments of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyaun 333, TaiwanDepartments of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyaun 333, TaiwanDepartments of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyaun 333, TaiwanDepartment of Hematology-Oncology, Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung 833, TaiwanDepartment of Hematology-Oncology, Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung 833, TaiwanDepartments of Hematology-Oncology, Chang Gung Memorial Hospital at Chiayi, Chiayi 612, TaiwanDepartment of Hematology-Oncology, Chang Gung Memorial Hospital at Keelung, Keelung 204, TaiwanDepartments of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyaun 333, TaiwanDepartments of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Taoyaun 333, TaiwanBackground: Few studies have reported the epidemiology and clinical outcome of venous thromboembolism (VTE) in Asian patients with pancreatic cancer. This study investigated the incidence, risk factors, and clinical outcome of VTE in patients with pancreatic cancer following palliative chemotherapy. Methods: The medical records of 838 patients with newly diagnosed locally advanced or metastatic pancreatic cancer who underwent palliative chemotherapy between 2010 and 2016 at four institutes in Taiwan were retrospectively reviewed. The clinical characteristics of all patients were analyzed to identify independent predictors of VTE and their effects on survival outcome. Results: During the median follow-up period of 7.7 months (range, 0.6⁻55.6), VTE occurred in 67 (8.0%) of the 838 patients. Leukocyte count > 11,000/μL and presence of liver metastases were the independent predictors of VTE. Patients with VTE did not show significantly poorer survival outcomes than those without VTE. However, early-onset VTE that occurred within 1.5 months after chemotherapy initiation was an independent negative prognosticator for overall survival. Conclusion: VTE incidence was found to be lower in Asian patients with pancreatic cancer than in their Western counterparts. Early-onset VTE, but not late-onset VTE, is a negative prognosticator for survival outcomes.https://www.mdpi.com/2072-6694/10/12/501pancreatic cancervenous thromboembolismincidencepredictoroutcome
spellingShingle Jen-Shi Chen
Chia-Yen Hung
Hung Chang
Chien-Ting Liu
Yen-Yang Chen
Chang-Hsien Lu
Pei-Hung Chang
Yu-Shin Hung
Wen-Chi Chou
Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
Cancers
pancreatic cancer
venous thromboembolism
incidence
predictor
outcome
title Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
title_full Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
title_fullStr Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
title_full_unstemmed Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
title_short Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset
title_sort venous thromboembolism in asian patients with pancreatic cancer following palliative chemotherapy low incidence but a negative prognosticator for those with early onset
topic pancreatic cancer
venous thromboembolism
incidence
predictor
outcome
url https://www.mdpi.com/2072-6694/10/12/501
work_keys_str_mv AT jenshichen venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT chiayenhung venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT hungchang venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT chientingliu venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT yenyangchen venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT changhsienlu venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT peihungchang venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT yushinhung venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset
AT wenchichou venousthromboembolisminasianpatientswithpancreaticcancerfollowingpalliativechemotherapylowincidencebutanegativeprognosticatorforthosewithearlyonset